US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell Endpoints.
GLOBAL — US biotechs turn tight-lipped on gene targets and pipelines as China's fast-follower threat intensifies, 20+ founders and investors tell Endpoints.
Image source: Endpoints.news
This report draws on reporting from Endpoints.news. DOCFLiX Desk has verified and adapted this report with additional context for our readers.
Read Original Story ↗